The Oncology Institute
TOI
41 hedge funds and large institutions have $39.2M invested in The Oncology Institute in 2022 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 20 increasing their positions, 6 reducing their positions, and 6 closing their positions.
233% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 6
50% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 6
5% more funds holding
Funds holding: 39 → 41 (+2)
0.14% more ownership
Funds ownership: 32.39% → 32.52% (+0.14%)
64% less capital invested
Capital invested by funds: $108M → $39.2M (-$69.2M)
100% less funds holding in top 10
Funds holding in top 10: 3 → 0 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PM
Prosight Management
Dallas,
Texas
|
+$773K |
| 2 |
JFG
Jefferies Financial Group
New York
|
+$540K |
| 3 |
TM
Triatomic Management
Palo Alto,
California
|
+$426K |
| 4 |
State Street
Boston,
Massachusetts
|
+$367K |
| 5 |
JAIC
Josh Arnold Investment Consultant
Edina,
Minnesota
|
+$293K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VCIM
Velan Capital Investment Management
Alpharetta,
Georgia
|
-$2.54M |
| 2 |
SCM
Saba Capital Management
New York
|
-$487K |
| 3 |
ZCM
Zebra Capital Management
Stamford,
Connecticut
|
-$127K |
| 4 |
JMPWA
JP Morgan Private Wealth Advisors
San Francisco,
California
|
-$85K |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
-$63.8K |
TOI Hedge Fund Activity: Q4 2022 in Review
41 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in The Oncology Institute (TOI) for Q4 2022, worth a combined $39.2M — down 64% from $108M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new TOI positions and 6 closed out — a net gain of 3 holders — while 20 added to existing stakes and 6 trimmed.
The largest buyer was Prosight Management, opening a new position worth an estimated $773K. The largest seller was Velan Capital Investment Management, exiting entirely with an estimated $2.54M sold.
- 41 institutional investors held The Oncology Institute (TOI) as of Q4 2022, up from 39 in Q3 2022.
- Funds reported $39.2M of The Oncology Institute stock for Q4 2022, down 64% quarter-over-quarter.
- 9 funds opened new The Oncology Institute positions in Q4 2022 and 6 closed out, a net change of +3 holders.
- The largest The Oncology Institute buyer in Q4 2022 was Prosight Management, an estimated $773K added.
- The largest The Oncology Institute seller in Q4 2022 was Velan Capital Investment Management, an estimated $2.54M sold.
Based on aggregated 13F filings for Q4 2022.